Preclinical
French company Innate Pharma and UK-based AstraZeneca have had a research collaboration deal in place since 2015. The two companies announced a new multi-term deal to build on that collaboration.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
HERA-CD40L Induces T-Cell-Mediated Anti-Tumor Immune Response through Activation of Antigen-Presenting Cells
Researchers at the University of Cambridge published research in the journal Nature Communications that suggests spontaneous DNA mutations may cause the majority of dementias.
HERA-CD40L Induces T-Cell-Mediated Anti-Tumor Immune Response through Activation of Antigen-Presenting Cells
Researchers at Johns Hopkins, the University of California, San Diego, and the National Institute of Mental Health grew retinas in petri dishes, and discovered fundamental factors involved in the development of vision and color vision.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Examples of new syndromes include hypotonia, ataxia, and delayed development syndrome (HADDS) and Sashi-Pena syndrome (SHAPNS).
In a monumental new breakthrough, scientists in Japan have created an immature human egg using stem cells that were created from blood cells. While immature human eggs have been successfully created in the lab before, this marks the first time that researchers have been able to do it using human blood.
CRISPR, the gene editing technique that scientists claim will lead to the cure and prevention of countless diseases and disorders, took a big step in that direction. Researchers at Children’s Hospital of Philadelphia (CHOP) used CRISPR to prevent a deadly metabolic disorder in prenatal laboratory animals.
PRESS RELEASES